{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:36:19Z","timestamp":1792787779736,"version":"4.5.0"},"reference-count":149,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"College Student Innovation and Entrepreneurship Training Program of Sichuan Province"},{"name":"Chengfei Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discover Nano"],"DOI":"10.1186\/s11671-026-04569-8","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T09:13:24Z","timestamp":1776244404000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Nanotechnology advances for psoriasis treatment and future prospects"],"prefix":"10.1186","volume":"21","author":[{"given":"Huilin","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziming","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"issue":"12","key":"4569_CR1","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1093\/rheumatology\/keae198","volume":"63","author":"S Lembke","year":"2024","unstructured":"Lembke S, Macfarlane GJ, Jones GT. The worldwide prevalence of psoriatic arthritis-a systematic review and meta-analysis. Rheumatology (Oxford). 2024;63(12):3211\u201320.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"4569_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.5114\/ada.2020.94832","volume":"37","author":"D Samotij","year":"2020","unstructured":"Samotij D, et al. Pathogenesis of psoriasis in the omic era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances. Postepy Dermatol Alergol. 2020;37(2):135\u201353.","journal-title":"Postepy Dermatol Alergol"},{"key":"4569_CR3","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v102.1386","volume":"102","author":"I Jalenques","year":"2022","unstructured":"Jalenques I, et al. Prevalence and Odds of Anxiety Disorders and Anxiety Symptoms in Children and Adults with Psoriasis: Systematic Review and Meta-analysis. Acta Derm Venereol. 2022;102:adv00769.","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"4569_CR4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2165\/00128071-200506060-00005","volume":"6","author":"AB Kimball","year":"2005","unstructured":"Kimball AB, et al. The psychosocial burden of psoriasis. Am J Clin Dermatol. 2005;6(6):383\u201392.","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"4569_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/JD9.0000000000000307","volume":"6","author":"Y-H Yu","year":"2023","unstructured":"Yu Y-H, et al. Epidemiology of depression and suicide ideation in patients with psoriasis: A meta-analysis of prospective cohort studies. International Journal of Dermatology and Venereology. 2023;6(2):78\u201386.","journal-title":"International Journal of Dermatology and Venereology"},{"issue":"5","key":"4569_CR6","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s13555-020-00435-2","volume":"10","author":"AG Wu","year":"2020","unstructured":"Wu AG, et al. Is clear always clear? Comparison of psoriasis area and severity index (PASI) and the physician\u2019s global assessment (PGA) in psoriasis clearance. Dermatol Ther. 2020;10(5):1155\u201363.","journal-title":"Dermatol Ther"},{"issue":"3","key":"4569_CR7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.7861\/clinmed.2021-0257","volume":"21","author":"A Raharja","year":"2021","unstructured":"Raharja A, Mahil SK, Barker JN. Psoriasis: A brief overview. Clin Med. 2021;21(3):170\u20133.","journal-title":"Clin Med"},{"issue":"6","key":"4569_CR8","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s13555-021-00612-x","volume":"11","author":"A Menter","year":"2021","unstructured":"Menter A, Van Voorhees AS, Hsu S. Pustular psoriasis: A narrative review of recent developments in pathophysiology and therapeutic options. Dermatol Ther. 2021;11(6):1917\u201329.","journal-title":"Dermatol Ther"},{"key":"4569_CR9","first-page":"1","volume":"12","author":"AKC Leung","year":"2023","unstructured":"Leung AKC, et al. Childhood guttate psoriasis: an updated review. Drugs Context. 2023;12:1\u201320.","journal-title":"Drugs Context"},{"issue":"2","key":"4569_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.abd.2023.05.007","volume":"99","author":"E Welsh","year":"2024","unstructured":"Welsh E, et al. Erythrodermic psoriasis treatment with Guselkumab: report of two cases and literature review. An Bras Dermatol. 2024;99(2):319\u201320.","journal-title":"An Bras Dermatol"},{"issue":"1","key":"4569_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.7861\/clinmedicine.17-1-65","volume":"17","author":"LC Coates","year":"2017","unstructured":"Coates LC, Helliwell PS. Psoriatic arthritis: state of the art review. Clin Med (Lond). 2017;17(1):65\u201370.","journal-title":"Clin Med (Lond)"},{"issue":"2","key":"4569_CR12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/jid.2012.339","volume":"133","author":"R Parisi","year":"2013","unstructured":"Parisi R, et al. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377\u201385.","journal-title":"J Invest Dermatol"},{"issue":"9583","key":"4569_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","volume":"370","author":"CE Griffiths","year":"2007","unstructured":"Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370(9583):263\u201371.","journal-title":"Lancet"},{"issue":"5","key":"4569_CR14","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMra0804595","volume":"361","author":"FO Nestle","year":"2009","unstructured":"Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361(5):496\u2013509.","journal-title":"N Engl J Med"},{"key":"4569_CR15","first-page":"131","volume":"6","author":"KE Benjegerdes","year":"2016","unstructured":"Benjegerdes KE, et al. Pustular psoriasis: pathophysiology and current treatment perspectives. Psoriasis (Auckl). 2016;6:131\u201344.","journal-title":"Psoriasis (Auckl)"},{"key":"4569_CR16","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2023-8-2","volume":"12","author":"AK Leung","year":"2023","unstructured":"Leung AK, et al. Childhood guttate psoriasis: an updated review. Drugs Context. 2023;12:2023\u20138\u20132.","journal-title":"Drugs Context"},{"key":"4569_CR17","first-page":"93","volume":"6","author":"RK Singh","year":"2016","unstructured":"Singh RK, et al. Erythrodermic psoriasis: pathophysiology and current treatment perspectives. Psoriasis (Auckl). 2016;6:93\u2013104.","journal-title":"Psoriasis (Auckl)"},{"key":"4569_CR18","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.19325","volume":"13","author":"MRS Chakith","year":"2025","unstructured":"Chakith MRS, et al. Advancements in understanding and treating psoriasis: a comprehensive review of pathophysiology, diagnosis, and therapeutic approaches. PeerJ. 2025;13:e19325.","journal-title":"PeerJ"},{"issue":"5","key":"4569_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054901","volume":"24","author":"AB Azuaga","year":"2023","unstructured":"Azuaga AB, Ram\u00edrez J, Ca\u00f1ete JD. Psoriatic arthritis: pathogenesis and targeted therapies. Int J Mol Sci. 2023;24(5):4901.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4569_CR20","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","volume":"8","author":"J Guo","year":"2023","unstructured":"Guo J, et al. Signaling pathways and targeted therapies for psoriasis. Signal Transduct Target Ther. 2023;8(1):437.","journal-title":"Signal Transduct Target Ther"},{"issue":"Suppl 1","key":"4569_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s40257-021-00658-9","volume":"23","author":"J Krueger","year":"2022","unstructured":"Krueger J, Puig L, Tha\u00e7i D. Treatment options and goals for patients with generalized pustular psoriasis. Am J Clin Dermatol. 2022;23(Suppl 1):51\u201364.","journal-title":"Am J Clin Dermatol"},{"issue":"10","key":"4569_CR22","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.it.2009.07.008","volume":"30","author":"H Valdimarsson","year":"2009","unstructured":"Valdimarsson H, et al. Psoriasis\u2013as an autoimmune disease caused by molecular mimicry. Trends Immunol. 2009;30(10):494\u2013501.","journal-title":"Trends Immunol"},{"issue":"4","key":"4569_CR23","doi-asserted-by":"publisher","DOI":"10.4081\/dr.2022.9448","volume":"14","author":"G Trevisan","year":"2022","unstructured":"Trevisan G, Germi L, Naldi L. Erythrodermic psoriasis improved by Tildrakizumab. Dermatol Rep. 2022;14(4):9448.","journal-title":"Dermatol Rep"},{"issue":"1","key":"4569_CR24","first-page":"42","volume":"43","author":"S Zhao","year":"2025","unstructured":"Zhao S, et al. Clinical features, treatment, and outcomes of nivolumab induced psoriasis. Invest New Drugs. 2025;43(1):42\u20139.","journal-title":"Invest New Drugs"},{"issue":"3","key":"4569_CR25","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1007\/s10637-025-01536-5","volume":"43","author":"M Shu","year":"2025","unstructured":"Shu M, et al. Retrospective analysis of clinical features of pembrolizumab induced psoriasis. Invest New Drugs. 2025;43(3):582\u20137.","journal-title":"Invest New Drugs"},{"issue":"19","key":"4569_CR26","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323(19):1945\u201360.","journal-title":"JAMA"},{"issue":"6","key":"4569_CR27","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/ijd.14246","volume":"58","author":"SB Kaushik","year":"2019","unstructured":"Kaushik SB, Lebwohl MG. Review of safety and efficacy of approved systemic psoriasis therapies. Int J Dermatol. 2019;58(6):649\u201358.","journal-title":"Int J Dermatol"},{"issue":"6","key":"4569_CR28","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jaad.2009.06.048","volume":"62","author":"ME de Jager","year":"2010","unstructured":"de Jager ME, et al. Efficacy and safety of treatments for childhood psoriasis: a systematic literature review. J Am Acad Dermatol. 2010;62(6):1013\u201330.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"4569_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/1346-8138.14213","volume":"45","author":"A Morita","year":"2018","unstructured":"Morita A. Current developments in phototherapy for psoriasis. J Dermatol. 2018;45(3):287\u201392.","journal-title":"J Dermatol"},{"issue":"1","key":"4569_CR30","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s00403-025-04148-4","volume":"317","author":"D Mente\u015fo\u011flu","year":"2025","unstructured":"Mente\u015fo\u011flu D, Kurmu\u015f GI, Kartal SP. Use of narrow-band ultraviolet B in pediatric dermatology patients: ten years of experience from a tertiary care hospital. Arch Dermatol Res. 2025;317(1):626.","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"4569_CR31","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3109\/09546634.2015.1133882","volume":"27","author":"A Maiorino","year":"2016","unstructured":"Maiorino A, et al. Melanoma and non-melanoma skin cancer in psoriatic patients treated with high-dose phototherapy. J Dermatolog Treat. 2016;27(5):443\u20137.","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"4569_CR32","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.abd.2021.03.001","volume":"96","author":"NM Barros","year":"2021","unstructured":"Barros NM, et al. Phototherapy. An Bras Dermatol. 2021;96(4):397\u2013407.","journal-title":"An Bras Dermatol"},{"issue":"5","key":"4569_CR33","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/j.1365-2133.1996.tb03886.x","volume":"135","author":"PC Van de Kerkhof","year":"1996","unstructured":"Van de Kerkhof PC, et al. Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo-controlled, double-blind study on efficacy and safety. Br J Dermatol. 1996;135(5):758\u201365.","journal-title":"Br J Dermatol"},{"key":"4569_CR34","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.2147\/DDDT.S304168","volume":"15","author":"P Rattanakaemakorn","year":"2021","unstructured":"Rattanakaemakorn P, et al. Incidence and risk factors of hepatic fibrosis in psoriatic patients receiving Methotrexate with concomitant Acitretin therapy and Methotrexate monotherapy. Drug Des Devel Ther. 2021;15:2299\u2013307.","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"4569_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/jdv.13746","volume":"31","author":"L Cai","year":"2017","unstructured":"Cai L, et al. Efficacy and safety of adalimumab in Chinese patients with moderate-to-severe plaque psoriasis: results from a phase 3, randomized, placebo-controlled, double-blind study. J Eur Acad Dermatol Venereol. 2017;31(1):89\u201395.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"4569_CR36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.5114\/ada.2019.91496","volume":"38","author":"N AlMutairi","year":"2021","unstructured":"AlMutairi N, Eassa BI. Comparing the efficacy and safety of IL-17 inhibitors for treatment of moderate-to-severe psoriasis: a randomized double blind pilot study with a review of literature. Postepy Dermatol Alergol. 2021;38(2):281\u20138.","journal-title":"Postepy Dermatol Alergol"},{"issue":"13","key":"4569_CR37","doi-asserted-by":"publisher","first-page":"7349","DOI":"10.3390\/ijms25137349","volume":"25","author":"S Rossi","year":"2024","unstructured":"Rossi S, et al. Functional genomics in psoriasis. Int J Mol Sci. 2024;25(13):7349.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4569_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s40264-023-01361-w","volume":"47","author":"B Strober","year":"2024","unstructured":"Strober B, et al. Long-term safety of Guselkumab in patients with psoriatic disease: an integrated analysis of eleven Phase II\/III clinical studies in psoriasis and psoriatic arthritis. Drug Saf. 2024;47(1):39\u201357.","journal-title":"Drug Saf"},{"issue":"1","key":"4569_CR39","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2024.2350760","volume":"35","author":"L Gargiulo","year":"2024","unstructured":"Gargiulo L, et al. Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study - IL PSO (Italian landscape psoriasis). J Dermatolog Treat. 2024;35(1):2350760.","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"4569_CR40","doi-asserted-by":"publisher","first-page":"460","DOI":"10.5114\/ada.2021.108445","volume":"39","author":"B Zhu","year":"2022","unstructured":"Zhu B, et al. Treatments in psoriasis: from standard pharmacotherapy to nanotechnology therapy. Postepy Dermatol Alergol. 2022;39(3):460\u201371.","journal-title":"Postepy Dermatol Alergol"},{"issue":"1","key":"4569_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02986-4","volume":"22","author":"J Li","year":"2024","unstructured":"Li J, et al. Microneedle patches incorporating zinc-doped mesoporous silica nanoparticles loaded with betamethasone dipropionate for psoriasis treatment. J Nanobiotechnology. 2024;22(1):706.","journal-title":"J Nanobiotechnology"},{"issue":"10284","key":"4569_CR42","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/S0140-6736(21)00440-2","volume":"397","author":"KA Papp","year":"2021","unstructured":"Papp KA, et al. IL17A\/F nanobody sonelokimab in patients with plaque psoriasis: a multicentre, randomised, placebo-controlled, phase 2b study. Lancet. 2021;397(10284):1564\u201375.","journal-title":"Lancet"},{"issue":"4","key":"4569_CR43","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1080\/17425247.2025.2472968","volume":"22","author":"CY Lin","year":"2025","unstructured":"Lin CY, et al. Novel strategies in topical delivery for psoriasis treatment: nanocarriers and energy-driven approaches. Expert Opin Drug Deliv. 2025;22(4):565\u201381.","journal-title":"Expert Opin Drug Deliv"},{"key":"4569_CR44","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejpb.2015.03.018","volume":"93","author":"E P\u00e9rez-Herrero","year":"2015","unstructured":"P\u00e9rez-Herrero E, Fern\u00e1ndez-Medarde A. Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm. 2015;93:52\u201379.","journal-title":"Eur J Pharm Biopharm"},{"key":"4569_CR45","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.colsurfb.2014.12.041","volume":"126","author":"M Estanqueiro","year":"2015","unstructured":"Estanqueiro M, et al. Nanotechnological carriers for cancer chemotherapy: the state of the art. Colloids Surf B Biointerfaces. 2015;126:631\u201348.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1","key":"4569_CR46","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2174\/1574891X113089990038","volume":"9","author":"ME Ruiz","year":"2014","unstructured":"Ruiz ME, Gantner ME, Talevi A. Applications of nanosystems to anticancer drug therapy (Part II. dendrimers, micelles, lipid-based nanosystems). Recent Pat Anticancer Drug Discov. 2014;9(1):99\u2013128.","journal-title":"Recent Pat Anticancer Drug Discov"},{"issue":"14","key":"4569_CR47","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s40265-015-0453-3","volume":"75","author":"S Marchal","year":"2015","unstructured":"Marchal S, et al. Anticancer drug delivery: an update on clinically applied nanotherapeutics. Drugs. 2015;75(14):1601\u201311.","journal-title":"Drugs"},{"key":"4569_CR48","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.smim.2017.08.010","volume":"34","author":"D Prosperi","year":"2017","unstructured":"Prosperi D, et al. Drug nanocarriers to treat autoimmunity and chronic inflammatory diseases. Semin Immunol. 2017;34:61\u20137.","journal-title":"Semin Immunol"},{"issue":"4","key":"4569_CR49","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3892\/ijo.2025.5789","volume":"67","author":"JX Si","year":"2025","unstructured":"Si JX, et al. Nanoparticle-based delivery systems for targeted therapy in brain tumors: Progress, challenges and perspectives (Review). Int J Oncol. 2025;67(4):83.","journal-title":"Int J Oncol"},{"issue":"8","key":"4569_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084153","volume":"23","author":"AM Hersh","year":"2022","unstructured":"Hersh AM, Alomari S, Tyler BM. Crossing the blood-brain barrier: advances in nanoparticle technology for drug delivery in neuro-oncology. Int J Mol Sci. 2022;23(8):4153.","journal-title":"Int J Mol Sci"},{"issue":"24","key":"4569_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/nano12244494","volume":"12","author":"O Afzal","year":"2022","unstructured":"Afzal O, et al. Nanoparticles in drug delivery: from history to therapeutic applications. Nanomaterials. 2022;12(24):4494.","journal-title":"Nanomaterials"},{"key":"4569_CR52","doi-asserted-by":"publisher","first-page":"8483","DOI":"10.2147\/IJN.S148359","volume":"12","author":"J Zhang","year":"2017","unstructured":"Zhang J, et al. Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy. Int J Nanomedicine. 2017;12:8483\u201393.","journal-title":"Int J Nanomedicine"},{"issue":"15","key":"4569_CR53","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/j.addr.2013.08.005","volume":"65","author":"BS Wong","year":"2013","unstructured":"Wong BS, et al. Carbon nanotubes for delivery of small molecule drugs. Adv Drug Deliv Rev. 2013;65(15):1964\u20132015.","journal-title":"Adv Drug Deliv Rev"},{"key":"4569_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2025.114747","volume":"253","author":"D M\u0171ller","year":"2025","unstructured":"M\u0171ller D, et al. Simple and hybrid materials for antimicrobial applications. Colloids Surf B Biointerfaces. 2025;253:114747.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"4569_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.114100","volume":"386","author":"M Algarra","year":"2025","unstructured":"Algarra M, et al. Recent developments in the use of carbon-based nanomaterials in cancer therapy. J Control Release. 2025;386:114100.","journal-title":"J Control Release"},{"issue":"9","key":"4569_CR56","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s00449-022-02733-9","volume":"45","author":"V Puspasari","year":"2022","unstructured":"Puspasari V, et al. ZnO-based antimicrobial coatings for biomedical applications. Bioprocess Biosyst Eng. 2022;45(9):1421\u201345.","journal-title":"Bioprocess Biosyst Eng"},{"key":"4569_CR57","doi-asserted-by":"publisher","first-page":"9395","DOI":"10.2147\/IJN.S216204","volume":"14","author":"B Lallo da Silva","year":"2019","unstructured":"Lallo da Silva B, et al. Relationship Between Structure And Antimicrobial Activity Of Zinc Oxide Nanoparticles: An Overview. Int J Nanomed. 2019;14:9395\u2013410.","journal-title":"Int J Nanomed"},{"issue":"9","key":"4569_CR58","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.drudis.2018.05.033","volume":"23","author":"NK Garg","year":"2018","unstructured":"Garg NK, et al. Lipid-polymer hybrid nanocarrier-mediated cancer therapeutics: current status and future directions. Drug Discov Today. 2018;23(9):1610\u201321.","journal-title":"Drug Discov Today"},{"key":"4569_CR59","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jconrel.2022.09.052","volume":"351","author":"E Elhassan","year":"2022","unstructured":"Elhassan E, et al. Engineering hybrid nanosystems for efficient and targeted delivery against bacterial infections. J Control Release. 2022;351:598\u2013622.","journal-title":"J Control Release"},{"key":"4569_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125380","volume":"673","author":"MT Khulood","year":"2025","unstructured":"Khulood MT, et al. Advances in metal-organic framework-based drug delivery systems. Int J Pharm. 2025;673:125380.","journal-title":"Int J Pharm"},{"issue":"8","key":"4569_CR61","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1016\/j.nano.2017.08.005","volume":"13","author":"AG Grigoras","year":"2017","unstructured":"Grigoras AG. Polymer-lipid hybrid systems used as carriers for insulin delivery. Nanomedicine. 2017;13(8):2425\u201337.","journal-title":"Nanomedicine"},{"issue":"3 Pt A","key":"4569_CR62","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ejpb.2013.07.002","volume":"85","author":"K Hadinoto","year":"2013","unstructured":"Hadinoto K, Sundaresan A, Cheow WS. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Eur J Pharm Biopharm. 2013;85(3 Pt A):427\u201343.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"4569_CR63","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1021\/acsnano.0c09382","volume":"15","author":"J Seaberg","year":"2021","unstructured":"Seaberg J, et al. Hybrid nanosystems for biomedical applications. ACS Nano. 2021;15(2):2099\u2013142.","journal-title":"ACS Nano"},{"issue":"2","key":"4569_CR64","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jconrel.2011.09.063","volume":"161","author":"T Lammers","year":"2012","unstructured":"Lammers T, et al. Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. J Control Release. 2012;161(2):175\u201387.","journal-title":"J Control Release"},{"issue":"19","key":"4569_CR65","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.2174\/092986712800784702","volume":"19","author":"JM Rabanel","year":"2012","unstructured":"Rabanel JM, et al. Drug-loaded nanocarriers: passive targeting and crossing of biological barriers. Curr Med Chem. 2012;19(19):3070\u2013102.","journal-title":"Curr Med Chem"},{"issue":"4","key":"4569_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17040478","volume":"17","author":"A Rani","year":"2025","unstructured":"Rani A, et al. Nanostructured lipid carriers (NLC)-based topical formulation of hesperidin for effective treatment of psoriasis. Pharmaceutics. 2025;17(4):478.","journal-title":"Pharmaceutics"},{"key":"4569_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124376","volume":"660","author":"N Assalem","year":"2024","unstructured":"Assalem N, et al. Therapeutic potential of Limonene-based Syringic acid nanoemulsion: enhanced ex-vivo cutaneous deposition and clinical anti-psoriatic efficacy. Int J Pharm. 2024;660:124376.","journal-title":"Int J Pharm"},{"issue":"9","key":"4569_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202410566","volume":"21","author":"H Chen","year":"2025","unstructured":"Chen H, et al. Controlled delivery of MTX from thermosensitive hydrogels using Au nanorods for enhanced therapeutics of psoriasis via improving stratum corneum penetration. Small. 2025;21(9):e2410566.","journal-title":"Small"},{"key":"4569_CR69","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.nano.2019.01.006","volume":"17","author":"I Fratoddi","year":"2019","unstructured":"Fratoddi I, et al. Effects of topical methotrexate loaded gold nanoparticle in cutaneous inflammatory mouse model. Nanomedicine. 2019;17:276\u201386.","journal-title":"Nanomedicine"},{"issue":"1","key":"4569_CR70","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.toxlet.2009.01.020","volume":"187","author":"MF Rahman","year":"2009","unstructured":"Rahman MF, et al. Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicol Lett. 2009;187(1):15\u201321.","journal-title":"Toxicol Lett"},{"key":"4569_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105469","volume":"152","author":"IA Tekko","year":"2020","unstructured":"Tekko IA, et al. Localised and sustained intradermal delivery of Methotrexate using nanocrystal-loaded microneedle arrays: potential for enhanced treatment of psoriasis. Eur J Pharm Sci. 2020;152:105469.","journal-title":"Eur J Pharm Sci"},{"key":"4569_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2025.123777","volume":"363","author":"S Liu","year":"2025","unstructured":"Liu S, et al. Delivery of penetration-enhancing antioxidant polyphenol nanoparticles with Codonopsis pilosula polysaccharide microneedles for synergistic treatment of psoriasis. Carbohydr Polym. 2025;363:123777.","journal-title":"Carbohydr Polym"},{"key":"4569_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113664","volume":"382","author":"J Yang","year":"2025","unstructured":"Yang J, et al. Transdermal psoriasis treatment inspired by tumor microenvironment-mediated immunomodulation and advanced by exosomal engineering. J Control Release. 2025;382:113664.","journal-title":"J Control Release"},{"issue":"6","key":"4569_CR74","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13113","volume":"32","author":"G Damiani","year":"2019","unstructured":"Damiani G, et al. Nanodermatology-based solutions for psoriasis: state-of-the art and future prospects. Dermatol Ther. 2019;32(6):e13113.","journal-title":"Dermatol Ther"},{"issue":"4","key":"4569_CR75","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1208\/s12249-025-03074-y","volume":"26","author":"M Alam","year":"2025","unstructured":"Alam M, et al. Co-delivery of Tacrolimus and Thymoquinone topically by nanostructured lipid carrier gel for enhanced efficacy against psoriasis. AAPS PharmSciTech. 2025;26(4):90.","journal-title":"AAPS PharmSciTech"},{"key":"4569_CR76","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ijpharm.2019.03.042","volume":"562","author":"S Jain","year":"2019","unstructured":"Jain S, et al. Comparative assessment of efficacy and safety potential of multifarious lipid based Tacrolimus loaded nanoformulations. Int J Pharm. 2019;562:96\u2013104.","journal-title":"Int J Pharm"},{"issue":"Pt 1","key":"4569_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.133005","volume":"273","author":"JS Lee","year":"2024","unstructured":"Lee JS, et al. Tacrolimus-loaded chitosan-based nanoparticles as an efficient topical therapeutic for the effective treatment of atopic dermatitis symptoms. Int J Biol Macromol. 2024;273(Pt 1):133005.","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"4569_CR78","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1517\/17425247.2012.666967","volume":"9","author":"C Puglia","year":"2012","unstructured":"Puglia C, Bonina F. Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals. Expert Opin Drug Deliv. 2012;9(4):429\u201341.","journal-title":"Expert Opin Drug Deliv"},{"issue":"6","key":"4569_CR79","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/02652048.2022.2116119","volume":"39","author":"P Todke","year":"2022","unstructured":"Todke P, et al. \u201cTransfersome-embedded-gel\u201d for dual-mechanistic delivery of anti-psoriatic drugs to dermal lymphocytes. J Microencapsul. 2022;39(6):495\u2013511.","journal-title":"J Microencapsul"},{"key":"4569_CR80","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jconrel.2014.09.021","volume":"196","author":"M Lapteva","year":"2014","unstructured":"Lapteva M, et al. Targeted cutaneous delivery of ciclosporin A using micellar nanocarriers and the possible role of inter-cluster regions as molecular transport pathways. J Control Release. 2014;196:9\u201318.","journal-title":"J Control Release"},{"issue":"5","key":"4569_CR81","doi-asserted-by":"publisher","first-page":"454","DOI":"10.2174\/1389200218666170222145240","volume":"18","author":"S Gungor","year":"2017","unstructured":"Gungor S, Rezigue M. Nanocarriers mediated topical drug delivery for psoriasis treatment. Curr Drug Metab. 2017;18(5):454\u201368.","journal-title":"Curr Drug Metab"},{"key":"4569_CR82","doi-asserted-by":"publisher","first-page":"1017126","DOI":"10.3389\/fmed.2022.1017126","volume":"9","author":"M Zhang","year":"2022","unstructured":"Zhang M, et al. Exploration of and insights into advanced topical nanocarrier systems for the treatment of psoriasis. Front Med (Lausanne). 2022;9:1017126.","journal-title":"Front Med (Lausanne)"},{"issue":"8","key":"4569_CR83","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1136\/ard.2004.030759","volume":"64","author":"M Higaki","year":"2005","unstructured":"Higaki M, et al. Treatment of experimental arthritis with poly(D, L-lactic\/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate. Ann Rheum Dis. 2005;64(8):1132\u20136.","journal-title":"Ann Rheum Dis"},{"key":"4569_CR84","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.2147\/IJN.S247007","volume":"15","author":"YO Agrawal","year":"2020","unstructured":"Agrawal YO, et al. Methotrexate-Loaded Nanostructured Lipid Carrier Gel Alleviates Imiquimod-Induced Psoriasis by Moderating Inflammation: Formulation, Optimization, Characterization, In-Vitro and In-Vivo Studies. Int J Nanomedicine. 2020;15:4763\u201378.","journal-title":"Int J Nanomedicine"},{"key":"4569_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122535","volume":"631","author":"GS Gomes","year":"2023","unstructured":"Gomes GS, et al. Nanotechnology-based alternatives for the topical delivery of immunosuppressive agents in psoriasis. Int J Pharm. 2023;631:122535.","journal-title":"Int J Pharm"},{"issue":"3","key":"4569_CR86","doi-asserted-by":"publisher","first-page":"336","DOI":"10.2174\/0118722105250901231201024930","volume":"19","author":"M Chadha","year":"2025","unstructured":"Chadha M, Malik DS. Vesicular nanocarriers: a potential platform for topical\/transdermal delivery of antibiotics. Recent Pat Nanotechnol. 2025;19(3):336\u201355.","journal-title":"Recent Pat Nanotechnol"},{"issue":"10","key":"4569_CR87","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/nnano.2016.135","volume":"11","author":"TK Kishimoto","year":"2016","unstructured":"Kishimoto TK, et al. Improving the efficacy and safety of biologic drugs with tolerogenic nanoparticles. Nat Nanotechnol. 2016;11(10):890\u20139.","journal-title":"Nat Nanotechnol"},{"issue":"11","key":"4569_CR88","doi-asserted-by":"publisher","first-page":"967","DOI":"10.4155\/tde-2017-0075","volume":"8","author":"E Kahraman","year":"2017","unstructured":"Kahraman E, G\u00fcng\u00f6r S, \u00d6zsoy Y. Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery. Ther Deliv. 2017;8(11):967\u201385.","journal-title":"Ther Deliv"},{"issue":"9","key":"4569_CR89","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1211\/0022357021701","volume":"55","author":"JV Aukunuru","year":"2003","unstructured":"Aukunuru JV, Ayalasomayajula SP, Kompella UB. Nanoparticle formulation enhances the delivery and activity of a vascular endothelial growth factor antisense oligonucleotide in human retinal pigment epithelial cells. J Pharm Pharmacol. 2003;55(9):1199\u2013206.","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"4569_CR90","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1476-5381.2009.00148.x","volume":"157","author":"E Fattal","year":"2009","unstructured":"Fattal E, Barratt G. Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA. Br J Pharmacol. 2009;157(2):179\u201394.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"4569_CR91","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ijpharm.2008.06.011","volume":"364","author":"E Fattal","year":"2008","unstructured":"Fattal E, Bochot A. State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers. Int J Pharm. 2008;364(2):237\u201348.","journal-title":"Int J Pharm"},{"issue":"1","key":"4569_CR92","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0169-409X(01)00245-9","volume":"54","author":"SV Vinogradov","year":"2002","unstructured":"Vinogradov SV, Bronich TK, Kabanov AV. Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. Adv Drug Deliv Rev. 2002;54(1):135\u201347.","journal-title":"Adv Drug Deliv Rev"},{"issue":"8","key":"4569_CR93","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202400968","volume":"26","author":"J Yang","year":"2025","unstructured":"Yang J, et al. Advances in drug delivery systems for atopic dermatitis treatment. Chembiochem. 2025;26(8):e202400968.","journal-title":"Chembiochem"},{"key":"4569_CR94","doi-asserted-by":"publisher","first-page":"5827","DOI":"10.2147\/DDDT.S240867","volume":"18","author":"K K\u0119dra","year":"2024","unstructured":"K\u0119dra K, Reich A. Clinical utility of various formulations of Calcipotriene and Betamethasone Dipropionate for the treatment of plaque psoriasis in patients aged 12 years or older. Drug Des Devel Ther. 2024;18:5827\u201339.","journal-title":"Drug Des Devel Ther"},{"key":"4569_CR95","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.2147\/CCID.S224211","volume":"13","author":"E Niculet","year":"2020","unstructured":"Niculet E, Bobeica C, Tatu AL. Glucocorticoid-induced skin atrophy: the old and the new. Clin Cosmet Investig Dermatol. 2020;13:1041\u201350.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"9","key":"4569_CR96","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3390\/pharmaceutics12090862","volume":"12","author":"J Frombach","year":"2020","unstructured":"Frombach J, et al. Serine protease-mediated cutaneous inflammation: characterization of an ex vivo skin model for the assessment of dexamethasone-loaded core multishell-nanocarriers. Pharmaceutics. 2020;12(9):862.","journal-title":"Pharmaceutics"},{"issue":"31","key":"4569_CR97","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202302314","volume":"12","author":"F Qu","year":"2023","unstructured":"Qu F, et al. Regulating size and charge of liposomes in microneedles to enhance intracellular drug delivery efficiency in skin for psoriasis therapy. Adv Healthc Mater. 2023;12(31):e2302314.","journal-title":"Adv Healthc Mater"},{"issue":"5","key":"4569_CR98","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/rheumatology\/kep023","volume":"48","author":"K Lindsay","year":"2009","unstructured":"Lindsay K, et al. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy. Rheumatology (Oxford). 2009;48(5):569\u201372.","journal-title":"Rheumatology (Oxford)"},{"key":"4569_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2023.10.035","author":"X Xin","year":"2023","unstructured":"Xin X, et al. Disease-specific corona mediated co-delivery of MTX and siRNA-TNF\u03b1 by a polypeptide nanoplatform with antigen-scavenging functions in psoriasis. J Control Release. 2023. https:\/\/doi.org\/10.1016\/j.jconrel.2023.10.035.","journal-title":"J Control Release"},{"key":"4569_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2021.102597","volume":"36","author":"L Lin","year":"2021","unstructured":"Lin L, et al. Nano-photosensitizers for enhanced photodynamic therapy. Photodiagnosis Photodyn Ther. 2021;36:102597.","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"9","key":"4569_CR101","doi-asserted-by":"publisher","first-page":"20523","DOI":"10.3390\/ijms160920523","volume":"16","author":"IO Bacellar","year":"2015","unstructured":"Bacellar IO, et al. Photodynamic efficiency: from molecular photochemistry to cell death. Int J Mol Sci. 2015;16(9):20523\u201359.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"4569_CR102","doi-asserted-by":"publisher","first-page":"9920","DOI":"10.1007\/s12274-024-6916-7","volume":"17","author":"X Ma","year":"2024","unstructured":"Ma X, et al. Foamed microemulsion nanodroplets loaded with chlorin e6 for epidermal-targeted treatment against psoriasis. Nano Res. 2024;17(11):9920\u201331.","journal-title":"Nano Res"},{"key":"4569_CR103","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jconrel.2022.07.006","volume":"349","author":"Y Mai","year":"2022","unstructured":"Mai Y, et al. Topical formulation based on disease-specific nanoparticles for single-dose cure of psoriasis. J Control Release. 2022;349:354\u201366.","journal-title":"J Control Release"},{"key":"4569_CR104","volume":"7","author":"P Zhu","year":"2024","unstructured":"Zhu P, et al. Aggregation-induced emission-active photosensitizer-mediated photodynamic therapy for anti-psoriasis. Research Wash D C. 2024;7:0344.","journal-title":"Research Wash D C"},{"issue":"1 Suppl 2","key":"4569_CR105","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1590\/0001-3765201720170800","volume":"90","author":"MQ Mesquita","year":"2018","unstructured":"Mesquita MQ, et al. An insight on the role of photosensitizer nanocarriers for photodynamic therapy. An Acad Bras Cienc. 2018;90(1 Suppl 2):1101\u201330.","journal-title":"An Acad Bras Cienc"},{"issue":"4","key":"4569_CR106","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.apsb.2016.01.007","volume":"6","author":"EJ Hong","year":"2016","unstructured":"Hong EJ, Choi DG, Shim MS. Targeted and effective photodynamic therapy for cancer using functionalized nanomaterials. Acta Pharm Sin B. 2016;6(4):297\u2013307.","journal-title":"Acta Pharm Sin B"},{"key":"4569_CR107","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/978-1-61779-052-2_11","volume":"726","author":"YE Lee","year":"2011","unstructured":"Lee YE, Kopelman R. Polymeric nanoparticles for photodynamic therapy. Methods Mol Biol. 2011;726:151\u201378.","journal-title":"Methods Mol Biol"},{"issue":"32","key":"4569_CR108","doi-asserted-by":"publisher","first-page":"17629","DOI":"10.1002\/anie.202105103","volume":"60","author":"S Cao","year":"2021","unstructured":"Cao S, et al. Biodegradable polymersomes with structure inherent fluorescence and targeting capacity for enhanced photo-dynamic therapy. Angew Chem Int Ed Engl. 2021;60(32):17629\u201337.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4569_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2021.118819","volume":"277","author":"Y Wang","year":"2022","unstructured":"Wang Y, et al. Chitosan\/hyaluronan nanogels co-delivering methotrexate and 5-aminolevulinic acid: a combined chemo-photodynamic therapy for psoriasis. Carbohydr Polym. 2022;277:118819.","journal-title":"Carbohydr Polym"},{"issue":"8","key":"4569_CR110","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1080\/1061186X.2024.2365930","volume":"32","author":"M Zewail","year":"2024","unstructured":"Zewail M, et al. Combined photodynamic therapy and hollow microneedle approach for effective non-invasive delivery of hypericin for the management of imiquimod-induced psoriasis. J Drug Target. 2024;32(8):941\u201352.","journal-title":"J Drug Target"},{"key":"4569_CR111","doi-asserted-by":"publisher","first-page":"9613","DOI":"10.2147\/IJN.S475531","volume":"19","author":"X Xu","year":"2024","unstructured":"Xu X, et al. Hepatoma-targeting and ROS-responsive polymeric micelle-based chemotherapy combined with photodynamic therapy for hepatoma treatment. Int J Nanomedicine. 2024;19:9613\u201335.","journal-title":"Int J Nanomedicine"},{"key":"4569_CR112","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.jconrel.2020.07.023","volume":"326","author":"A Sahu","year":"2020","unstructured":"Sahu A, et al. Catalytic nanographene oxide with hemin for enhanced photodynamic therapy. J Control Release. 2020;326:442\u201354.","journal-title":"J Control Release"},{"issue":"10","key":"4569_CR113","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29102224","volume":"29","author":"O Yeshchenko","year":"2024","unstructured":"Yeshchenko O, et al. Third-generation anticancer photodynamic therapy systems based on star-like anionic polyacrylamide polymer, gold nanoparticles, and temoporfin photosensitizer. Molecules. 2024;29(10):2224.","journal-title":"Molecules"},{"issue":"1","key":"4569_CR114","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-11165-w","volume":"15","author":"Y Liu","year":"2025","unstructured":"Liu Y, et al. Light-activated multimodal nanoplatform for enhanced synergistic therapy of breast cancer. Sci Rep. 2025;15(1):25995.","journal-title":"Sci Rep"},{"issue":"2","key":"4569_CR115","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.apsb.2024.12.020","volume":"15","author":"L Su","year":"2025","unstructured":"Su L, et al. Topical adhesive spatio-temporal nanosystem co-delivering chlorin e6 and HMGB1 inhibitor glycyrrhizic acid for in situ psoriasis chemo-phototherapy. Acta Pharm Sin B. 2025;15(2):1126\u201342.","journal-title":"Acta Pharm Sin B"},{"issue":"10","key":"4569_CR116","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1021\/ar4003009","volume":"47","author":"L Gu","year":"2014","unstructured":"Gu L, et al. Sugar-based amphiphilic polymers for biomedical applications: from nanocarriers to therapeutics. Acc Chem Res. 2014;47(10):2867\u201377.","journal-title":"Acc Chem Res"},{"issue":"13","key":"4569_CR117","doi-asserted-by":"publisher","first-page":"3779","DOI":"10.1039\/C8SC04844D","volume":"10","author":"X Yang","year":"2019","unstructured":"Yang X, et al. Functional black phosphorus nanosheets for mitochondria-targeting photothermal\/photodynamic synergistic cancer therapy. Chem Sci. 2019;10(13):3779\u201385.","journal-title":"Chem Sci"},{"issue":"2","key":"4569_CR118","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3109\/1061186X.2014.958844","volume":"23","author":"P Tharkar","year":"2015","unstructured":"Tharkar P, et al. Nanoparticulate carriers: an emerging tool for breast cancer therapy. J Drug Target. 2015;23(2):97\u2013108.","journal-title":"J Drug Target"},{"issue":"11","key":"4569_CR119","doi-asserted-by":"publisher","first-page":"5632","DOI":"10.3390\/ijms25115632","volume":"25","author":"S Yu","year":"2024","unstructured":"Yu S, et al. Noble metal nanoparticle-based photothermal therapy: development and application in effective cancer therapy. Int J Mol Sci. 2024;25(11):5632.","journal-title":"Int J Mol Sci"},{"key":"4569_CR120","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jconrel.2016.10.028","volume":"246","author":"F Teodorescu","year":"2017","unstructured":"Teodorescu F, et al. Photothermally triggered on-demand insulin release from reduced graphene oxide modified hydrogels. J Control Release. 2017;246:164\u201373.","journal-title":"J Control Release"},{"issue":"4","key":"4569_CR121","doi-asserted-by":"publisher","first-page":"6517","DOI":"10.1021\/acsnano.0c08790","volume":"15","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, et al. Temperature-sensitive lipid-coated carbon nanotubes for synergistic photothermal therapy and gene therapy. ACS Nano. 2021;15(4):6517\u201329.","journal-title":"ACS Nano"},{"issue":"34","key":"4569_CR122","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.2174\/1381612825666181120160959","volume":"24","author":"Y Xu","year":"2018","unstructured":"Xu Y, et al. Advanced carbon-based nanoplatforms combining drug delivery and thermal therapy for cancer treatment. Curr Pharm Des. 2018;24(34):4060\u201376.","journal-title":"Curr Pharm Des"},{"issue":"43","key":"4569_CR123","doi-asserted-by":"publisher","first-page":"48310","DOI":"10.1021\/acsami.0c13364","volume":"12","author":"J Wu","year":"2020","unstructured":"Wu J, et al. Ultrathin transition metal chalcogenide nanosheets synthesized via topotactic transformation for effective cancer theranostics. Acs Appl Mater Interfaces. 2020;12(43):48310\u201320.","journal-title":"Acs Appl Mater Interfaces"},{"key":"4569_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115070","volume":"165","author":"K Qi","year":"2023","unstructured":"Qi K, et al. Research progress on carbon materials in tumor photothermal therapy. Biomed Pharmacother. 2023;165:115070.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4569_CR125","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1186\/s12951-024-02909-3","volume":"22","author":"Y Li","year":"2024","unstructured":"Li Y, et al. Photothermal Fe3O4 nanoparticles induced immunogenic ferroptosis for synergistic colorectal cancer therapy. J Nanobiotechnology. 2024;22(1):630.","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"4569_CR126","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1186\/s12951-024-02992-6","volume":"22","author":"X Deng","year":"2024","unstructured":"Deng X, et al. FeS2@COF based nanocarrier for photothermal-enhanced chemodynamic\/thermodynamic tumor therapy and immunotherapy via reprograming tumor-associated macrophages. J Nanobiotechnology. 2024;22(1):711.","journal-title":"J Nanobiotechnology"},{"issue":"11","key":"4569_CR127","doi-asserted-by":"publisher","DOI":"10.3390\/nano15110796","volume":"15","author":"R Sawamura","year":"2025","unstructured":"Sawamura R, et al. Selective photothermal therapy using antioxidant nanoparticles encapsulating novel near-infrared-absorbing platinum(II) complexes. Nanomaterials. 2025;15(11):796.","journal-title":"Nanomaterials"},{"issue":"15","key":"4569_CR128","doi-asserted-by":"publisher","first-page":"11902","DOI":"10.1039\/D4RA09100K","volume":"15","author":"A Holca","year":"2025","unstructured":"Holca A, et al. Recent advances in gold nanoparticle-graphene hybrid nanoplatforms with visible to near-infrared response for photodynamic and photothermal therapy and bioimaging. RSC Adv. 2025;15(15):11902\u201322.","journal-title":"RSC Adv"},{"key":"4569_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.101668","volume":"32","author":"X Zhu","year":"2025","unstructured":"Zhu X, et al. Two-dimensional graphene nanomaterials for combined photothermal and chemotherapy-enhanced targeted therapy of breast cancer. Mater Today Bio. 2025;32:101668.","journal-title":"Mater Today Bio"},{"key":"4569_CR130","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.nantod.2018.02.010","volume":"19","author":"S Gai","year":"2018","unstructured":"Gai S, et al. Recent advances in functional nanomaterials for light\u2013triggered cancer therapy. Nano Today. 2018;19:146\u201387.","journal-title":"Nano Today"},{"issue":"13","key":"4569_CR131","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202107071","volume":"18","author":"D Zhang","year":"2022","unstructured":"Zhang D, et al. Combination of photothermal therapy with anti-inflammation therapy attenuates the inflammation tumor microenvironment and weakens immunosuppression for enhancement antitumor treatment. Small. 2022;18(13):e2107071.","journal-title":"Small"},{"issue":"33","key":"4569_CR132","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202400361","volume":"20","author":"Z Chen","year":"2024","unstructured":"Chen Z, et al. NIR absorbing organic chromophores combination with NSAIDs for remodeling of the inflammatory microenvironment to amplify tumor ferroptosis-photothermal synergistic therapy. Small. 2024;20(33):e2400361.","journal-title":"Small"},{"issue":"20","key":"4569_CR133","doi-asserted-by":"publisher","first-page":"e2304421","DOI":"10.1002\/adhm.202304421","volume":"13","author":"L Zhao","year":"2024","unstructured":"Zhao L, et al. A Cyanine with 83.2% Photothermal Conversion Efficiency and Absorption Wavelengths over 1200 nm for Photothermal Therapy. Adv Healthc Mater. 2024;13(20):e2304421.","journal-title":"Adv Healthc Mater"},{"key":"4569_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2023.123668","volume":"308","author":"W Wei","year":"2024","unstructured":"Wei W, et al. Novel small molecule-based organic nanoparticles for second near-infrared photothermal tumor ablation. Spectrochim Acta A Mol Biomol Spectrosc. 2024;308:123668.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"issue":"11","key":"4569_CR135","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1021\/acs.bioconjchem.7b00508","volume":"28","author":"W Wang","year":"2017","unstructured":"Wang W, et al. Metal-organic frameworks@polymer composites containing cyanines for near-infrared fluorescence imaging and photothermal tumor therapy. Bioconjug Chem. 2017;28(11):2784\u201393.","journal-title":"Bioconjug Chem"},{"key":"4569_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2021.100198","volume":"13","author":"C Li","year":"2022","unstructured":"Li C, et al. Self-assembled porphyrin polymer nanoparticles with NIR-II emission and highly efficient photothermal performance in cancer therapy. Mater Today Bio. 2022;13:100198.","journal-title":"Mater Today Bio"},{"key":"4569_CR137","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.actbio.2018.09.045","volume":"81","author":"P Xue","year":"2018","unstructured":"Xue P, et al. Calcium-carbonate packaging magnetic polydopamine nanoparticles loaded with indocyanine green for near-infrared induced photothermal\/photodynamic therapy. Acta Biomater. 2018;81:242\u201355.","journal-title":"Acta Biomater"},{"key":"4569_CR138","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jconrel.2021.04.005","volume":"333","author":"GR Nirmal","year":"2021","unstructured":"Nirmal GR, et al. Photothermal treatment by PLGA-gold nanorod-isatin nanocomplexes under near-infrared irradiation for alleviating psoriasiform hyperproliferation. J Control Release. 2021;333:487\u201399.","journal-title":"J Control Release"},{"issue":"Pt 1","key":"4569_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2025.114985","volume":"256","author":"Q Chang","year":"2025","unstructured":"Chang Q, et al. Hyaluronic acid-modified Fe(3)O(4) for magnetic-targeted photothermal suppression of psoriasis-like skin hyperplasia. Colloids Surf B Biointerfaces. 2025;256(Pt 1):114985.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1","key":"4569_CR140","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.apsb.2024.08.030","volume":"15","author":"K Mao","year":"2025","unstructured":"Mao K, et al. Optimized lipid nanoparticles enable effective CRISPR\/Cas9-mediated gene editing in dendritic cells for enhanced immunotherapy. Acta Pharm Sin B. 2025;15(1):642\u201356.","journal-title":"Acta Pharm Sin B"},{"key":"4569_CR141","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.canlet.2019.01.017","volume":"447","author":"M Chen","year":"2019","unstructured":"Chen M, et al. CRISPR-Cas9 for cancer therapy: opportunities and challenges. Cancer Lett. 2019;447:48\u201355.","journal-title":"Cancer Lett"},{"issue":"11","key":"4569_CR142","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abe2888","volume":"7","author":"T Wan","year":"2021","unstructured":"Wan T, Pan Q, Ping Y. Microneedle-assisted genome editing: a transdermal strategy of targeting NLRP3 by CRISPR-Cas9 for synergistic therapy of inflammatory skin disorders. Sci Adv. 2021;7(11):796.","journal-title":"Sci Adv"},{"issue":"12","key":"4569_CR143","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","volume":"54","author":"MG Alameh","year":"2021","unstructured":"Alameh MG, et al. Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses. Immunity. 2021;54(12):2877-2892.e7.","journal-title":"Immunity"},{"key":"4569_CR144","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.2147\/IJN.S504639","volume":"20","author":"A Zeng","year":"2025","unstructured":"Zeng A, et al. Using siRNA-based anti-inflammatory lipid nanoparticles for gene regulation in psoriasis. Int J Nanomedicine. 2025;20:4519\u201333.","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"4569_CR145","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1007\/s13346-020-00723-6","volume":"10","author":"JSR Viegas","year":"2020","unstructured":"Viegas JSR, et al. Nanostructured lipid carrier co-delivering tacrolimus and TNF-\u03b1 siRNA as an innovate approach to psoriasis. Drug Deliv Transl Res. 2020;10(3):646\u201360.","journal-title":"Drug Deliv Transl Res"},{"issue":"14","key":"4569_CR146","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.2217\/nnm.13.202","volume":"9","author":"S Marepally","year":"2014","unstructured":"Marepally S, et al. Topical administration of dual siRNAs using fusogenic lipid nanoparticles for treating psoriatic-like plaques. Nanomedicine (Lond). 2014;9(14):2157\u201374.","journal-title":"Nanomedicine (Lond)"},{"issue":"1","key":"4569_CR147","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03214-3","volume":"23","author":"S Zhang","year":"2025","unstructured":"Zhang S, et al. Somatostatin receptor-targeted polymeric nanoplatform for efficient CRISPR\/Cas9 gene editing to enhance synergistic hepatocellular carcinoma therapy. J Nanobiotechnology. 2025;23(1):127.","journal-title":"J Nanobiotechnology"},{"issue":"4","key":"4569_CR148","first-page":"417","volume":"52","author":"J Wang","year":"2023","unstructured":"Wang J, et al. Advances in modification and delivery of nucleic acid drugs. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023;52(4):417\u201328.","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"issue":"33","key":"4569_CR149","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303706","volume":"10","author":"M Zhang","year":"2023","unstructured":"Zhang M, et al. Transcutaneous immunotherapy for RNAi: a cascade-responsive decomposable nanocomplex based on polyphenol-mediated framework nucleic acid in psoriasis. Adv Sci. 2023;10(33):e2303706.","journal-title":"Adv Sci"}],"container-title":["Discover Nano"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-026-04569-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11671-026-04569-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-026-04569-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T10:02:18Z","timestamp":1776247338000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11671-026-04569-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":149,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4569"],"URL":"https:\/\/doi.org\/10.1186\/s11671-026-04569-8","relation":{},"ISSN":["2731-9229"],"issn-type":[{"value":"2731-9229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This review article does not involve any new studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the final version of the manuscript and consent to its submission and publication. For any figures reproduced from previously published sources, the necessary permissions have been obtained from the copyright holders.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"122"}}